AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Blueprint Medicines Corp
  3. Financials
  4. Cash and cash equivalents

Blueprint Medicines Corp【BPMC】

Market cap
$8.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024114+39.39%
Dec 31, 202382-34.73%
Dec 31, 2022125-41.94%
Dec 31, 2021215-68.81%
Dec 31, 2020690+476.74%
Dec 31, 2019120+62.88%
Dec 31, 201873-81.66%
Dec 31, 2017400+668.80%
Dec 31, 201652-68.00%
Dec 31, 2015163

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)